Is Briacell Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BCTX) stock is to Buy BCTX stock.
Out of 1 analyst, 0 (0%) are recommending BCTX as a Strong Buy, 1 (100%) are recommending BCTX as a Buy, 0 (0%) are recommending BCTX as a Hold, 0 (0%) are recommending BCTX as a Sell, and 0 (0%) are recommending BCTX as a Strong Sell.
What is BCTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: BCTX) forecast ROE is N/A, which is considered weak.
What is BCTX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BCTX price target, the average BCTX price target is $25.00, with the highest BCTX stock price forecast at $25.00 and the lowest BCTX stock price forecast at $25.00.
The Wall Street analyst predicted that Briacell Therapeutics's share price could reach $25.00 by Feb 24, 2024. The average Briacell Therapeutics stock price prediction forecasts a potential upside of 302.58% from the current BCTX share price of $6.21.
What is BCTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: BCTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.